Evidence map›Paper›PMID 30648131›Full record

ArticleOpen forum infectious diseases2019

Randomized Controlled Pilot Study of Antiretrovirals and a Behavioral Intervention for Persons With Acute HIV Infection: Opportunity for Interrupting Transmission.

William C Miller, Sarah E Rutstein, Sam Phiri, Gift Kamanga, Dominic Nsona, Dana K Pasquale, Katherine B Rucinski, Jane S Chen, Carol E Golin, Kimberly A Powers and 6 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

William C MillerDivision of Epidemiology, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-1934-7827
Sarah E RutsteinDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Sam PhiriLighthouse Trust, Lilongwe, Malawi.
Gift KamangaUNC Project, Lilongwe, Malawi.
Dominic NsonaLighthouse Trust, Lilongwe, Malawi.
Dana K PasqualeDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Katherine B RucinskiDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Jane S ChenDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Carol E GolinDepartment of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Kimberly A PowersDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Ann M DennisDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Mina C HosseinipourDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Joseph J EronDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Wairimu ChegeDivision of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Irving F HoffmanDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Audrey E PettiforDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
University of North Carolina at Chapel Hill · USLighthouse Trust · MWNational Institutes of Health · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
Acute HIV infection - A key link for transmission preventionR01AI083059 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MILLER, WILLIAM C, PETTIFOR, AUDREY · 2009 to 2012
$3.7M
Reaching Unaware Sexual and Social Contacts to Interrupt Ongoing HIV TransmissionR01AI114320 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MILLER, WILLIAM C, POWERS, KIMBERLY A · 2014 to 2017
$2.5M
Optimizing HIV Therapy: virological monitoring, adherence & cost-effectivenessF30MH098731 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUTSTEIN, SARAH E. · 2012 to 2016
$201k
NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI083059NIAID NIH HHS R01 AI114320NIAID NIH HHS T32 AI070114NIAID NIH HHS T32 AI102623NICHD NIH HHS P2C HD050924NIMH NIH HHS F30 MH098731
6 · The paper itself

Abstract

backgroundPersons with acute HIV infection (AHI) have heightened transmission risk. We evaluated potential transmission reduction using behavioral and biomedical interventions in a randomized controlled pilot study in Malawi.

methodsPersons were randomized 1:2:2 to standard counseling (SC), 5-session behavioral intervention (BI), or behavioral intervention plus 12 weeks of antiretrovirals (ARVs; BIA). All were followed for 26-52 weeks and, regardless of arm, referred for treatment according to Malawi-ARV guidelines. Participants were asked to refer partners for testing.

resultsAmong 46 persons (9 SC, 18 BI, 19 BIA), the average age was 28; 61% were male. The median viral load (VL) was 5.9 log copies/mL at enrollment. 67% (10/15) of BIA participants were suppressed (<1000 copies/mL) at week 12 vs 25% BI and 50% SC (

conclusionsDiagnosis of AHI facilitates behavioral and biomedical risk reduction strategies during a high-transmission period that begins years before people are typically identified and started on ARVs. Sexually transmitted infection incidence in this cohort suggests ongoing risk behaviors, reinforcing the importance of early intervention with ARVs to reduce transmission. Early diagnosis coupled with standard AHI counseling and early ARV referral quickly suppresses viremia, may effectively change behavior, and could have tremendous public health benefit in reducing onward transmission.

Indexed as

acute HIV infectionHIVMalawimotivational interviewingtransmission

Identifiers

PMID30648131
PMCPMC6329906
OpenAlexW2904075408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.